Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation
NCT04320680 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2025-02-04
Summary
Diagnosis and follow up of a lupus cohort in a multidisciplinary consultation in Brest ( France)
Conditions
Interventions
- OTHER
-
description of a lupus patient cohort
description of a lupus patient cohort
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-13
- Primary Completion
- 2025-05-13
- Completion
- 2025-05-13
Countries
- France
Study Locations
More Related Trials
-
Systemic Lupus Erythematosus and Accelerated Aging
NCT05698173 ·Status: RECRUITING ·Phase: NA
-
ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
NCT06593041 ·Status: RECRUITING
-
Regulatory BCells in Systemic Lupus Erythematosus
NCT03178721 ·Status: UNKNOWN
-
Covid-19 in Lupus Patients
NCT04355702 ·Status: COMPLETED
-
Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus
NCT06506214 ·Status: COMPLETED
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus
NCT02364908 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients
NCT02922114 ·Status: COMPLETED ·Phase: NA
-
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
NCT06491602 ·Status: RECRUITING
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
IL-26 and Systemic Lupus Erythematosus
NCT01889641 ·Status: TERMINATED
-
Lupus Cohort--Thrombotic Events and Coronary Artery Disease
NCT00005436 ·Status: COMPLETED
-
Identifying New Therapeutic Targets for Lupus Treatment
NCT03921398 ·Status: COMPLETED
-
3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol
NCT05458622 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
NCT03575156 ·Status: COMPLETED ·Phase: NA
-
Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.
NCT02891213 ·Status: UNKNOWN
-
HLA Antibodies in Systemic Lupus Erythematosus
NCT06921239 ·Status: RECRUITING
-
Anti-ficolin-2 Autoantibodies in Lupus Nephritis
NCT03063281 ·Status: COMPLETED
-
Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
NCT02926560 ·Status: COMPLETED
-
International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus
NCT01509989 ·Status: COMPLETED
-
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage
NCT04558814 ·Status: UNKNOWN ·Phase: NA
-
Autophagy in Systemic Lupus Erythematosus
NCT03583853 ·Status: UNKNOWN
-
Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment
NCT02330250 ·Status: COMPLETED ·Phase: NA
-
The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS
NCT00413361 ·Status: COMPLETED ·Phase: PHASE4